STMPatch - SingleTimeMicroneedles

📍 Storrs, United States🗓 Founded 2022👥 9 employees💰 Last funded May 2024

SingleTimeMicroneedles’ mission is to improve community health multiple doses at a time. Our work on multi-dose thermally-stable microneedle patches will increase access to lifesaving veterinary and human pharmaceuticals and supplements. We have developed a drug/vaccine microneedle delivery platform that eliminates the need for cold-chain storage and transportation and are the only patches that can deliver doses immediately, over-time, or separately over weeks/months in one application. The core technology of STM is a vaccine patch which can be painlessly applied at a single time on the skin to embed arrays of microneedles (MNs) inside the superficial skin layer (like an invisible tattoo). The MNs are made of a safe biodegradable polymer (used for surgical suture) and pre-programmed to release vaccines repeatedly over a long period, mimicking the effect of multiple prime/booster doses in the traditional vaccination process. The APIs are stabilized against high temperatures, thus avoiding the need of cold-chain storage facilities and affirming the antigenicity for a long-term skin embedment. The technology will revolutionize the vaccination process by 1. eliminating biohazard waste 2. reducing personnel time (one dose, easy application) 3. enabling a high immunogenic efficacy via transdermal delivery 4. increasing patient compliance to dosing schedules 5. eliminate needle sticks for workers Applications include human supplements, animal health products, and human pharmaceuticals.

Total investors

Early stage

Mid stage

Late stage

2022

Founded